Latest Breaking News On - Vista pharmaceuticals - Page 4 : comparemela.com

KalVista Pharmaceuticals (NASDAQ:KALV) Stock Price Up 6 8%

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) rose 6.8% on Wednesday . The stock traded as high as $12.13 and last traded at $12.12. Approximately 71,232 shares traded hands during trading, a decline of 90% from the average daily volume of 700,371 shares. The stock had previously closed at $11.35. Wall Street Analysts Forecast […]

United statesNew yorkEdwardp feenerYork state common retirement fundChina universal asset management coInstitutional trading of kalvista pharmaceuticalsNews ratings for kalvista pharmaceuticals dailyNeedham companyMirae asset global investments coVanguard group incKalvista pharmaceuticals incKalvista pharmaceuticalsKalvista pharmaceuticals stockSg americas securitiesGet free reportVista pharmaceuticals

KalVista Pharmaceuticals (NASDAQ:KALV) Stock Price Up 6 8%

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report)’s stock price was up 6.8% on Wednesday . The stock traded as high as $12.13 and last traded at $12.12. Approximately 71,232 shares were traded during trading, a decline of 90% from the average daily volume of 700,371 shares. The stock had previously closed at $11.35. Analyst […]

United statesBenjaminl palleikoThomas andrew crockettFrazier life sciences managementAffinity asset advisorsNews ratings for kalvista pharmaceuticals dailyKalvista pharmaceuticals tradingInstitutional trading of kalvista pharmaceuticalsNeedham companyKalvista pharmaceuticals company profileNan fung group holdings ltdKalvista pharmaceuticalsSg americas securitiesVanguard group incKalvista pharmaceuticals incGet free report

KalVista Pharmaceuticals Appoints William C Fairey to Board of Directors

KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that.

United statesWilliamc faireyBen palleikoMary college of californiaCompany board of directorsMyokardia incKalvista pharmaceuticals incUniversity of oregonExchange commissionChemocentryx incActelion pharmaceuticalsKalvista pharmaceuticalsChief commercial officerChief operating officerVice presidentAsia pacific region

KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference

KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced its.

Drug administrationKalvista pharmaceuticals incExchange commissionKalvista pharmaceuticalsAnnual needham virtual healthcare conferenceVista pharmaceuticalsSecurities litigation reform act

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Kalvista pharmaceuticals incKalvista pharmaceuticalsNasdaq listing ruleInducement equity incentive planVista pharmaceuticals